Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity

References

• World Health Organization. Immunization Coverage: Fact Sheet Number 378. http://www.who.int/mediacentre/factsheets/fs378/en/.2016
   Google Scholar
• O'Hagan DT, Ott GS, Nest GV, Rappuoli R, Giudice GD. The history of MF59® adjuvant: a phoenix that arose from the ashes. Expert Rev Vaccines 2013; 12(1):13-30; PMID:23256736; http://dx.doi.org/10.1586/erv.12.140
   PubMed Web of Science ®Google Scholar
• Garcon N, Morel S, Didierlaurent A, Descamps D, Wettendorff M, Van MM. Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach. BioDrugs 2011; 25(4):217-26; PMID:21815697; http://dx.doi.org/10.2165/11591760-000000000-00000
   PubMed Web of Science ®Google Scholar
• Kates M. Archaebacterial lipids: structure, biosynthesis and function. Biochem Soc Symp 1992; 58:51-72; PMID:1445410
   PubMedGoogle Scholar
• Sprott GD. Structures of archaebacterial membrane lipids. J Bioenerg Biomembr 1992; 24(6):555-66; PMID:1459987; http://dx.doi.org/10.1007/BF00762348
   PubMed Web of Science ®Google Scholar
• Haq K, Jia Y, Krishnan L. Archaeal lipid vaccine adjuvants for induction of cell-mediated immunity. Expert Rev Vaccines 2016; 15(12):1557-66; PMID:27276183; http://dx.doi.org/10.1080/14760584.2016.1195265
   PubMed Web of Science ®Google Scholar
• Conlan JW, Krishnan L, Willick GE, Patel GB, Sprott GD. Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various Archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pathogen, Listeria monocytogenes. Vaccine 2001; 19(25–26):3509-17; PMID:11348718; http://dx.doi.org/10.1016/S0264-410X(01)00041-X
   PubMed Web of Science ®Google Scholar
• Krishnan L, Deschatelets L, Stark FC, Gurnani K, Sprott GD. Archaeosome adjuvant overcomes tolerance to tumor-associated melanoma antigens inducing protective CD8 T cell responses. Clin Dev Immunol 2010; 2010:578432; PMID:21318177; http://dx.doi.org/10.1155/2010/578432
   PubMedGoogle Scholar
• Sprott GD, Yeung A, Dicaire CJ, Yu SH, Whitfield DM. Synthetic archaeosome vaccines containing triglycosylarchaeols can provide additive and long-lasting immune responses that are enhanced by archaetidylserine. Archaea 2012; 2012:513231; PMID:23055819; http://dx.doi.org/10.1155/2012/513231
   PubMed Web of Science ®Google Scholar
• Krishnan L, Dicaire CJ, Patel GB, Sprott G. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum. Infect Immun 2000; 68(1):54-63; PMID:10603368; http://dx.doi.org/10.1128/IAI.68.1.54-63.2000
   PubMed Web of Science ®Google Scholar
• Sprott GD, Sad S, Fleming LP, Dicaire CJ, Patel GB, Krishnan L. Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen. Archaea 2003; 1(3):151-64; PMID:15803661; http://dx.doi.org/10.1155/2003/569283
   PubMedGoogle Scholar
• Ansari MA, Zubair S, Tufail S, Ahmad E, Khan MR, Quadri Z, Owais M. Ether lipid vesicle-based antigens impart protection against experimental listeriosis. Int J Nanomedicine 2012; 7:2433-47; PMID:22745536; http://dx.doi.org/10.2147/IJN.S25875
   PubMedGoogle Scholar
• Higa LH, Corral RS, Morilla MJ, Romero EL, Petray PB. Archaeosomes display immunoadjuvant potential for a vaccine against Chagas disease. Hum Vaccin Immunother 2013; 9(2):409-12; PMID:23291939; http://dx.doi.org/10.4161/hv.22780
   PubMed Web of Science ®Google Scholar
• Ansari MA, Zubair S, Mahmood A, Gupta P, Khan AA, Gupta UD, Arora A, Owais M. RD antigen based nanovaccine imparts long term protection by inducing memory response against experimental murine tuberculosis. PLoS One 2011; 6(8):e22889; PMID:21853054; http://dx.doi.org/10.1371/journal.pone.0022889
   PubMed Web of Science ®Google Scholar
• Stark FC, McCluskie MJ, Krishnan L. Homologous Prime-Boost Vaccination with OVA Entrapped in Self-Adjuvanting Archaeosomes Induces High Numbers of OVA-Specific CD8(+) T Cells that Protect Against Subcutaneous B16-OVA Melanoma. Vaccines (Basel) 2016; 4(4):pii: E44; PMID:27869670
   PubMed Web of Science ®Google Scholar
• Patel GB, Zhou H, Ponce A, Harris G, Chen W. Intranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challenge. PLoS One 2010; 5(12):e15574; PMID:21206916; http://dx.doi.org/10.1371/journal.pone.0015574
   PubMed Web of Science ®Google Scholar
• Patel GB, Chen W. Archaeal lipid mucosal vaccine adjuvant and delivery system. Expert Rev Vaccines 2010; 9(4):431-40; PMID:20370552; http://dx.doi.org/10.1586/erv.10.34
   PubMed Web of Science ®Google Scholar
• Patel GB, Zhou H, Ponce A, Chen W. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines. Vaccine 2007; 25(51):8622-36; PMID:17959279; http://dx.doi.org/10.1016/j.vaccine.2007.09.042
   PubMed Web of Science ®Google Scholar
• Higa LH, Arnal L, Vermeulen M, Perez AP, Schilrreff P, Mundina-Weilenmann C, Yantorno O, Vela ME, Morilla MJ, Romero EL. Ultradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis Antigens. PLoS One 2016; 11(3):e0150185; PMID:26934726; http://dx.doi.org/10.1371/journal.pone.0150185
   PubMed Web of Science ®Google Scholar
• Higa LH, Schilrreff P, Perez AP, Iriarte MA, Roncaglia DI, Morilla MJ, Romero EL. Ultradeformable archaeosomes as new topical adjuvants. Nanomedicine 2012; 8(8):1319-28; PMID:22366598; http://dx.doi.org/10.1016/j.nano.2012.02.008
   PubMed Web of Science ®Google Scholar
• Whitfield DM, Yu SH, Dicaire CJ, Sprott GD. Development of new glycosylation methodologies for the synthesis of archaeal-derived glycolipid adjuvants. Carbohydr Res 2010; 345(2):214-29; PMID:20004891; http://dx.doi.org/10.1016/j.carres.2009.10.011
   PubMed Web of Science ®Google Scholar
• Sprott GD, Larocque S, Cadotte N, Dicaire CJ, McGee M, Brisson JR. Novel polar lipids of halophilic eubacterium Planococcus H8 and archaeon Haloferax volcanii. Biochim Biophys Acta 2003; 1633(3):179-88; PMID:14499737; http://dx.doi.org/10.1016/j.bbalip.2003.08.001
   PubMed Web of Science ®Google Scholar
• Sprott GD, Patel GB, Krishnan L. Archaeobacterial ether lipid liposomes as vaccine adjuvants. Methods Enzymol 2003; 373:155-72; PMID:14714403
   PubMed Web of Science ®Google Scholar
• Layre E, Paepe DC, Larrouy-Maumus G, Vaubourgeix J, Mundayoor S, Lindner B, Puzo G, Gilleron M. Deciphering sulfoglycolipids of Mycobacterium tuberculosis. J Lipid Res 2011; 52(6):1098-110; PMID:21482713; http://dx.doi.org/10.1194/jlr.M013482
   PubMed Web of Science ®Google Scholar
• Gilleron M, Stenger S, Mazorra Z, Wittke F, Mariotti S, Bohmer G, Prandi J, Mori L, Puzo G, De LG. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J Exp Med 2004; 199(5):649-59; PMID:14981115; http://dx.doi.org/10.1084/jem.20031097
   PubMed Web of Science ®Google Scholar
• Mohammad O, Kaur J, Singh G, Faisal SM, Azhar A, Rauf MA, Gupta UD, Gupta P, Pal R, Zubair S. TLR agonist augments prophylactic potential of acid inducible antigen Rv3203 against mycobacterium tuberculosis H37Rv in experimental animals. PLoS One 2016; 11(3):e0152240; PMID:27023750; http://dx.doi.org/10.1371/journal.pone.0152240
   PubMed Web of Science ®Google Scholar
• Barbeau J, Cammas-Marion S, Auvray P, Benvegnu T. Preparation and characterization of stealth archaeosomes based on a synthetic PEGylated archaeal tetraether lipid. J Drug Deliv 2011; 2011:396068; PMID:21603209; http://dx.doi.org/10.1155/2011/396068
   PubMedGoogle Scholar
• Gonzalez-Paredes A, Clares-Naveros B, Ruiz-Martinez MA, Durban-Fornieles JJ, Ramos-Cormenzana A, Monteoliva-Sanchez M. Delivery systems for natural antioxidant compounds: Archaeosomes and archaeosomal hydrogels characterization and release study. Int J Pharm 2011; 421(2):321-31; PMID:21986112; http://dx.doi.org/10.1016/j.ijpharm.2011.09.042
   PubMed Web of Science ®Google Scholar
• Whitfield DM, Sprott GD, Krishnan L. Sulfated-Glycolipids As Adjuvants for Vaccines. Jan 14, 2016
   Google Scholar
• Krishnan L, Gurnani K, Dicaire CJ, van Faassen H, Zafer A, Kirschning CJ, Sad S, Sprott GD. Rapid clonal expansion and prolonged maintenance of memory CD8+ T cells of the effector (CD44highCD62Llow) and central (CD44highCD62Lhigh) phenotype by an archaeosome adjuvant independent of TLR2. J Immunol 2007; 178(4):2396-406; PMID:17277146; http://dx.doi.org/10.4049/jimmunol.178.4.2396
   PubMed Web of Science ®Google Scholar
• Krishnan L, Sad S, Patel GB, Sprott GD. Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge. Cancer Res 2003; 63(10):2526-34; PMID:12750276
   PubMed Web of Science ®Google Scholar